Studies showed that ITGBL1 could promote the invasion of ovarian cancer cell through Wnt/planar cell polarity (PCP) signaling and focal adhesion kinase (FAK)/Src pathway (2), and high expression of ITGBL1 was related to the poor prognosis and drug resistance of ovarian cancer (3). Here, PTK2 is linked to ovarian carcinoma.